Platelet to lymphocyte ratio predicts all-cause mortality in patients with carotid arterial disease

1. KAPLAN ZS., JACKSON SP. The role of platelets in atherothrombosis. Hematology Am Soc Hematol Educ Program 2011; 2011:51-61.10.1182/asheducation-2011.1.51Search in Google Scholar

2. OMMEN SR., GİBBONS RJ., HODGE DO., THOMPSON SP. Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. Am J Cardiol 1997:79;812-4.10.1016/S0002-9149(96)00878-8Search in Google Scholar

3. PETERSEN AK., KRUMSİEK J., WÄGELE B., THEİS FJ., WİCHMANN HE., GİEGER C. On the hypothesis-free testing of metabolite ratios in genome-wide and metabolome-wide association studies. BMC Bioinformatics. 2012 Jun 6;13:120.10.1186/1471-2105-13-120353759222672667Search in Google Scholar

4. LEE YSG., BARADİ A., PEVERELLE M., SULTANİ R., ADAMS H, GARLİCK J., et al. Usefulness of Platelet-to-Lymphocyte Ratio to Predict Long-Term All-Cause Mortality in Patients at High Risk of Coronary Artery Disease Who Underwent Coronary Angiography. Am J Cardiol. 2018 May 1;121(9):1021-1026.10.1016/j.amjcard.2018.01.01829606325Search in Google Scholar

5. YÜKSEL M., YILDIZ A., OYLUMLU M., AKYÜZ A., AYDIN M., KAYA H., et al. The association between platelet/lymphocyte ratio and coronary artery disease severity. Anatol J Cardiol. 2015 Aug; 15(8):640-7.10.5152/akd.2014.5565533686525550173Search in Google Scholar

6. BHATTİ I., PEACOCK O., LLOYD G., LARVİN M., HALL RI. Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. Am J Surg. 2010;200:197-203.10.1016/j.amjsurg.2009.08.04120122680Search in Google Scholar

7. GURSOY OM., KARAKOYUN S., KALCİK M., GOKDENİZ T., YESİN M., GUNDUZ S., et al. Usefulness of novel hematologic inflammatory parameters to predict prosthetic mitral valve thrombosis. Am J Cardiol. 2014;113:860-864.10.1016/j.amjcard.2013.11.02924411287Search in Google Scholar

8. GARY T., PİCHLER M., BELAJ K., HAFNER F., GERGER A., FROEHLİCH H., et al. Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. PLoS One. 2013;8:e67688.10.1371/journal.pone.0067688369963423844064Search in Google Scholar

9. WİTKİEWİCZ W., KLİMECZEK P., IWANOWSKİ W., PASİCKA B., DOŁEGA-KOZİEROWSKİ B., DRELİCHOWSKİ S., et al. Dual source computed tomography in analysis of significance and morphology carotid plaques. Przegl Lek. 2013;70(3):118-122.Search in Google Scholar

10. LİAPİS CD., BELL PR., MİKHAİLİDİSM D., et al. ESVS guidelines. İnvasive treatment for carotid stenosis: indications, techniques. Eur J Vasc Endovasc Surg 2009; 37:1-19.10.1016/j.ejvs.2008.11.00619286127Search in Google Scholar

11. SOYLU İA., CORTCU SA., UZUNKAYA F., ATALAY YO., BEKÇİ T., GÜNGÖR L., et al. The correlation of the platelet-to-lymphocyte ratio with the severity of stenosis and stroke in patients with carotid arterial disease. Vascular. 2017 Jun;25(3):299-306.10.1177/170853811667377027770030Search in Google Scholar

12. VARIM C., VARIM P., ACAR BA., VATAN MB., UYANIK MS., KAYA T., et al. Usefulness of the platelet-to-lymphocyte ratio in predicting the severity of carotid artery stenosis in patients undergoing carotid angiography. Kaohsiung Journal of Medical Sciences (2016) 32, 86-90.10.1016/j.kjms.2015.12.007Search in Google Scholar

13. MONETA GL, EDWARDS JM, TAYLOR LM JR, CHİTWOOD RW, LEE RW, CUMMİNGS CA et al. Correlation of North American Symtomatic Carotid Endarterectomy Trial (NASCET) angiographic definition of 70% to 99% internal carotid artery stenosis with duplex scanning. J Vase Surg. 1993;17(1):152-159.10.1016/0741-5214(93)90019-ISearch in Google Scholar

14. BALTA S., OZTURK C. The platelet-lymphocyte ratio: A simple, inexpensive and rapid prognostic marker for cardiovascular events. Platelets. 2015;26(7):680-1.10.3109/09537104.2014.97934025549287Search in Google Scholar

15. DURMUŞ E., KIVRAK T., GERİN F., SUNBUL M., SARİ I., ERDOGAN O. Neutrophil-to-lymphocyte ratio and and Platelet-to-Lymphocyte Ratio are Predictors of Heart Failure. Send to Arq Bras Cardiol. 2015 Dec;105(6):606-13.10.5935/abc.20150126469366526536980Search in Google Scholar

16. AKDAĞ S., AKYOL A., ASKER M., DUZ R., GUMRUKCUOGLU HA. Platelet-to-Lymphocyte Ratio May Predict the Severity of Calcific Aortic Stenosis. Med Sci Monit. 2015 Nov 6;21:3395-400.10.12659/MSM.894774Search in Google Scholar

17. DERELİ S., BAYRAMOĞLU A., YONTAR OC. Usefulness of platelet to lymphocyte ratiofor predicting recurrence of atrial fibrillation after direct current cardioversion. Ann Noninvasive Electrocardiol. 2018 Nov 10:e12616.10.1111/anec.12616693175330414335Search in Google Scholar

18. YILDIZ A., YUKSEL M., OYLUMLU M., POLAT N., AKYUZ A., ACET H., et al. The utility of the platelet-lymphocyte ratio for predicting no reflow in patients with ST-segment elevation myocardial ınfarction. Clin Appl Thromb Hemost 2015 Apr;21(3):223-8.10.1177/107602961351985124431380Search in Google Scholar

19. YAYLA Ç., AKBOĞA MK., CANPOLAT U. Platelet to lymphocyte ratio can be a predictor of infarct-related artery patency in patients with ST-segment elevation myocardial infarction. Angiology. 2015 Oct;66(9):831-6.10.1177/000331971557365825712290Search in Google Scholar

20. TEMİZ A., GAZİ E., GÜNGÖR Ö. Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction. Med Sci Monit. 2014;20:660-665.10.12659/MSM.890152399915924751474Search in Google Scholar

21. OZCAN CETİN EH., CETİN MS., ARAS D., TOPALOGLU S, TEMİZHAN A, KİSACİK HL., et al. Platelet to lymphocyte ratio as a prognostic marker of in-hospital and long-term major adverse cardiovascular events in-hospital and long-term major adverse cardiovascular events in ST segment elevation myocardial infarction. Angiology 2016;67:336-345.10.1177/000331971559175126101368Search in Google Scholar

22. AYÇA B., AKİN F., OKUYAN E. Platelet to lymphocyte ratio as a prognostic marker in primary percutaneous coronary intervention. Platelets. 2015;26(8):816.10.3109/09537104.2015.101541025807323Search in Google Scholar

23. AZAB B., SHAH N., AKERMAN M., MCGİNN JT JR. Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis. 2012 Oct;34(3):326-34.10.1007/s11239-012-0718-622466812Search in Google Scholar

24. OSADNİK T., WASİLEWSKİ J., LEKSTON A., STRZELCZYK J., KUREK A., GONERA M., et al. The platelet-tolymphocyte ratio as a predictor of all-cause mortality in patients with coronary artery disease undergoing elective percutaneous coronary intervention and stent implantation. Saudi Heart Assoc. 2015 Jul;27(3):144-51.10.1016/j.jsha.2015.02.004448142026136628Search in Google Scholar

25. BOULOS NM., GARDİN JM., MALİK S., POSTLEY J., WONG ND. Carotid plaque characterization, stenosis, and ıntimamedia thickness according to age and gender in a large registry cohort. Am J Cardiol. 2016 Apr 1;117(7):1185-91.10.1016/j.amjcard.2015.12.062537135026869392Search in Google Scholar

26. HANSSON GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352:1685-95.10.1056/NEJMra04343015843671Search in Google Scholar

27. DOH JH., KOO BK., NAM CW., KİM JH., MİN JK., NAKAZATO R., et al. Diagnostic value of coronary CT angiography in comparison with invasive coronary angiography and intravascular ultrasound in patients with intermediate coronary artery stenosis: results from the prospective multicentre FIGURE-OUT (Functional Imaging criteria for GUiding REview of invasive coronary angiOgraphy, intravascular Ultrasound, and coronary computed Tomographic angiography) study. Eur Heart J Cardiovasc Imaging. 2014 Aug;15(8):870-7.10.1093/ehjci/jeu009411088524513881Search in Google Scholar